Crossmark

In vitro drug sensitivity (IDS) of patient-derived primary osteosarcoma cells as an early predictor of the clinical outcomes of osteosarcoma patients

Published Online: 2020-05-31

Published Print: 2020-06

Authors

Klangjorhor, Jeerawan

Phanphaisarn, Areerak

Teeyakasem, Pimpisa

Chaiyawat, Parunya

Phinyo, Phichayut

Settakorn, Jongkolnee

Theera-Umpon, Nipon

Pruksakorn, Dumnoensun https://orcid.org/0000-0002-5358-9336
Funding

Funding for this research was provided by:

National Science and Technology Development Agency (P-18-51991)
License Information

Text and Data Mining valid from 2020-05-31

Version of Record valid from 2020-05-31
More Information

Article History

Received: 5 February 2020

Accepted: 13 May 2020

First Online: 31 May 2020

Compliance with ethical standards

:

: All the authors declare no conflict of interest.

: The research protocol was reviewed and approved by the Research Ethics Committee 1 and 4, Faculty of Medicine, Chiang Mai University (ethics approval code ORT-11-09-16A-14 (ID#757) for phase 1 and ORT-2557-0271 (ID#2717) for phase 2). Fully informed consent was obtained from all participants included in the study, in conformity with institutional guidelines.

Document is current